Cargando…

Multifactorial assessment of Parkinson’s disease course and outcomes using trajectory modeling in a multiethnic, multisite cohort – extension of the LONG-PD study

BACKGROUND: The severity, progression, and outcomes of motor and non-motor symptoms in Parkinson’s disease (PD) are quite variable. Following PD cohorts holds promise for identifying predictors of disease severity and progression. METHODS: PD patients (N = 871) were enrolled at five sites. Enrollmen...

Descripción completa

Detalles Bibliográficos
Autores principales: Chase, Bruce A., Krueger, Rejko, Pavelka, Lukas, Chung, Sun Ju, Aasly, Jan, Dardiotis, Efthimios, Premkumar, Ashvini P., Schoneburg, Bernadette, Kartha, Ninith, Aunaetitrakul, Navamon, Frigerio, Roberta, Maraganore, Demetrius, Markopoulou, Katerina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10569724/
https://www.ncbi.nlm.nih.gov/pubmed/37842125
http://dx.doi.org/10.3389/fnagi.2023.1240971
_version_ 1785119610883801088
author Chase, Bruce A.
Krueger, Rejko
Pavelka, Lukas
Chung, Sun Ju
Aasly, Jan
Dardiotis, Efthimios
Premkumar, Ashvini P.
Schoneburg, Bernadette
Kartha, Ninith
Aunaetitrakul, Navamon
Frigerio, Roberta
Maraganore, Demetrius
Markopoulou, Katerina
author_facet Chase, Bruce A.
Krueger, Rejko
Pavelka, Lukas
Chung, Sun Ju
Aasly, Jan
Dardiotis, Efthimios
Premkumar, Ashvini P.
Schoneburg, Bernadette
Kartha, Ninith
Aunaetitrakul, Navamon
Frigerio, Roberta
Maraganore, Demetrius
Markopoulou, Katerina
author_sort Chase, Bruce A.
collection PubMed
description BACKGROUND: The severity, progression, and outcomes of motor and non-motor symptoms in Parkinson’s disease (PD) are quite variable. Following PD cohorts holds promise for identifying predictors of disease severity and progression. METHODS: PD patients (N = 871) were enrolled at five sites. Enrollment occurred within 5 years of initial motor symptom onset. Disease progression was assessed annually for 2-to-10 years after onset. Group-based trajectory modeling was used to identify groups differing in disease progression. Models were developed for UPDRS-III scores, UPDRS-III tremor and bradykinesia-rigidity subscores, Hoehn & Yahr (H&Y) stage, Mini-Mental Status Exam (MMSE) scores, and UPDRS-III, H&Y and MMSE scores considered together. Predictors of trajectory-group membership were modeled simultaneously with the trajectories. Kaplan–Meier survival analysis evaluated survival free of PD outcomes. RESULTS: The best fitting models identified three groups. One showed a relatively benign, slowly progressing trajectory (Group 1), a second showed a moderate, intermediately progressing trajectory (Group 2), and a third showed a more severe, rapidly progressing trajectory (Group 3). Stable trajectory-group membership occurred relatively early in the disease course, 5 years after initial motor symptom. Predictors of intermediate and more severe trajectory-group membership varied across the single variable models and the multivariable model jointly considering UPDRS-III, H&Y and MMSE scores. In the multivariable model, membership in Group 2 (28.4% of patients), relative to Group 1 (50.5%), was associated with male sex, younger age-at-onset, fewer education-years, pesticide exposure, absence of reported head injury, and akinetic/rigid subtype at initial presentation. Membership in Group 3 (21.3%), relative to Group 1, was associated with older age-at-onset, fewer education-years, pesticide exposure, and the absence of a tremor-predominant subtype at initial presentation. Persistent freezing, persistent falls, and cognitive impairment occurred earliest and more frequently in Group 3, later and less frequently in Group 2, and latest and least frequently in Group 1. Furthermore, autonomic complications, dysphagia, and psychosis occurred more frequently in Groups 2 and 3 than in Group 1. CONCLUSION: Modeling disease course using multiple objective assessments over an extended follow-up duration identified groups that more accurately reflect differences in PD course, prognosis, and outcomes than assessing single parameters over shorter intervals.
format Online
Article
Text
id pubmed-10569724
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-105697242023-10-13 Multifactorial assessment of Parkinson’s disease course and outcomes using trajectory modeling in a multiethnic, multisite cohort – extension of the LONG-PD study Chase, Bruce A. Krueger, Rejko Pavelka, Lukas Chung, Sun Ju Aasly, Jan Dardiotis, Efthimios Premkumar, Ashvini P. Schoneburg, Bernadette Kartha, Ninith Aunaetitrakul, Navamon Frigerio, Roberta Maraganore, Demetrius Markopoulou, Katerina Front Aging Neurosci Aging Neuroscience BACKGROUND: The severity, progression, and outcomes of motor and non-motor symptoms in Parkinson’s disease (PD) are quite variable. Following PD cohorts holds promise for identifying predictors of disease severity and progression. METHODS: PD patients (N = 871) were enrolled at five sites. Enrollment occurred within 5 years of initial motor symptom onset. Disease progression was assessed annually for 2-to-10 years after onset. Group-based trajectory modeling was used to identify groups differing in disease progression. Models were developed for UPDRS-III scores, UPDRS-III tremor and bradykinesia-rigidity subscores, Hoehn & Yahr (H&Y) stage, Mini-Mental Status Exam (MMSE) scores, and UPDRS-III, H&Y and MMSE scores considered together. Predictors of trajectory-group membership were modeled simultaneously with the trajectories. Kaplan–Meier survival analysis evaluated survival free of PD outcomes. RESULTS: The best fitting models identified three groups. One showed a relatively benign, slowly progressing trajectory (Group 1), a second showed a moderate, intermediately progressing trajectory (Group 2), and a third showed a more severe, rapidly progressing trajectory (Group 3). Stable trajectory-group membership occurred relatively early in the disease course, 5 years after initial motor symptom. Predictors of intermediate and more severe trajectory-group membership varied across the single variable models and the multivariable model jointly considering UPDRS-III, H&Y and MMSE scores. In the multivariable model, membership in Group 2 (28.4% of patients), relative to Group 1 (50.5%), was associated with male sex, younger age-at-onset, fewer education-years, pesticide exposure, absence of reported head injury, and akinetic/rigid subtype at initial presentation. Membership in Group 3 (21.3%), relative to Group 1, was associated with older age-at-onset, fewer education-years, pesticide exposure, and the absence of a tremor-predominant subtype at initial presentation. Persistent freezing, persistent falls, and cognitive impairment occurred earliest and more frequently in Group 3, later and less frequently in Group 2, and latest and least frequently in Group 1. Furthermore, autonomic complications, dysphagia, and psychosis occurred more frequently in Groups 2 and 3 than in Group 1. CONCLUSION: Modeling disease course using multiple objective assessments over an extended follow-up duration identified groups that more accurately reflect differences in PD course, prognosis, and outcomes than assessing single parameters over shorter intervals. Frontiers Media S.A. 2023-09-26 /pmc/articles/PMC10569724/ /pubmed/37842125 http://dx.doi.org/10.3389/fnagi.2023.1240971 Text en Copyright © 2023 Chase, Krueger, Pavelka, Chung, Aasly, Dardiotis, Premkumar, Schoneburg, Kartha, Aunaetitrakul, Frigerio, Maraganore and Markopoulou. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Aging Neuroscience
Chase, Bruce A.
Krueger, Rejko
Pavelka, Lukas
Chung, Sun Ju
Aasly, Jan
Dardiotis, Efthimios
Premkumar, Ashvini P.
Schoneburg, Bernadette
Kartha, Ninith
Aunaetitrakul, Navamon
Frigerio, Roberta
Maraganore, Demetrius
Markopoulou, Katerina
Multifactorial assessment of Parkinson’s disease course and outcomes using trajectory modeling in a multiethnic, multisite cohort – extension of the LONG-PD study
title Multifactorial assessment of Parkinson’s disease course and outcomes using trajectory modeling in a multiethnic, multisite cohort – extension of the LONG-PD study
title_full Multifactorial assessment of Parkinson’s disease course and outcomes using trajectory modeling in a multiethnic, multisite cohort – extension of the LONG-PD study
title_fullStr Multifactorial assessment of Parkinson’s disease course and outcomes using trajectory modeling in a multiethnic, multisite cohort – extension of the LONG-PD study
title_full_unstemmed Multifactorial assessment of Parkinson’s disease course and outcomes using trajectory modeling in a multiethnic, multisite cohort – extension of the LONG-PD study
title_short Multifactorial assessment of Parkinson’s disease course and outcomes using trajectory modeling in a multiethnic, multisite cohort – extension of the LONG-PD study
title_sort multifactorial assessment of parkinson’s disease course and outcomes using trajectory modeling in a multiethnic, multisite cohort – extension of the long-pd study
topic Aging Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10569724/
https://www.ncbi.nlm.nih.gov/pubmed/37842125
http://dx.doi.org/10.3389/fnagi.2023.1240971
work_keys_str_mv AT chasebrucea multifactorialassessmentofparkinsonsdiseasecourseandoutcomesusingtrajectorymodelinginamultiethnicmultisitecohortextensionofthelongpdstudy
AT kruegerrejko multifactorialassessmentofparkinsonsdiseasecourseandoutcomesusingtrajectorymodelinginamultiethnicmultisitecohortextensionofthelongpdstudy
AT pavelkalukas multifactorialassessmentofparkinsonsdiseasecourseandoutcomesusingtrajectorymodelinginamultiethnicmultisitecohortextensionofthelongpdstudy
AT chungsunju multifactorialassessmentofparkinsonsdiseasecourseandoutcomesusingtrajectorymodelinginamultiethnicmultisitecohortextensionofthelongpdstudy
AT aaslyjan multifactorialassessmentofparkinsonsdiseasecourseandoutcomesusingtrajectorymodelinginamultiethnicmultisitecohortextensionofthelongpdstudy
AT dardiotisefthimios multifactorialassessmentofparkinsonsdiseasecourseandoutcomesusingtrajectorymodelinginamultiethnicmultisitecohortextensionofthelongpdstudy
AT premkumarashvinip multifactorialassessmentofparkinsonsdiseasecourseandoutcomesusingtrajectorymodelinginamultiethnicmultisitecohortextensionofthelongpdstudy
AT schoneburgbernadette multifactorialassessmentofparkinsonsdiseasecourseandoutcomesusingtrajectorymodelinginamultiethnicmultisitecohortextensionofthelongpdstudy
AT karthaninith multifactorialassessmentofparkinsonsdiseasecourseandoutcomesusingtrajectorymodelinginamultiethnicmultisitecohortextensionofthelongpdstudy
AT aunaetitrakulnavamon multifactorialassessmentofparkinsonsdiseasecourseandoutcomesusingtrajectorymodelinginamultiethnicmultisitecohortextensionofthelongpdstudy
AT frigerioroberta multifactorialassessmentofparkinsonsdiseasecourseandoutcomesusingtrajectorymodelinginamultiethnicmultisitecohortextensionofthelongpdstudy
AT maraganoredemetrius multifactorialassessmentofparkinsonsdiseasecourseandoutcomesusingtrajectorymodelinginamultiethnicmultisitecohortextensionofthelongpdstudy
AT markopouloukaterina multifactorialassessmentofparkinsonsdiseasecourseandoutcomesusingtrajectorymodelinginamultiethnicmultisitecohortextensionofthelongpdstudy